Abbott Receives FDA Approval for Gallant Heart Rhythm Implants Featuring Continuous Remote Monitoring

Abbott FDA Approval Gallant Heart Rhythm Implants
Entrance to Abbott Ireland at Cootehill (Image credit: Eric Jones, via geograph)
Abbott won FDA approval for its next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. Cleared in Europe earlier this year, the implants feature Bluetooth connectivity, […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleWT | Studio Talk: OMRON – How Wearables Are Evolving Heart Health Monitoring & Patient Outcomes
Next articleInnovative Applications Pushing The Popularity Of Wearable Devices
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)wearable-technologies.com.